Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

48.42
BATS BZX Real-Time Price
As of 11:43am ET
 -0.43 / -0.88%
Today’s Change
45.69
Today|||52-Week Range
61.70
-8.33%
Year-to-Date

Today’s Trading

Previous close48.85
Today’s open48.98
Day’s range48.31 - 49.11
Volume3,630,970
Average volume (3 months)11,618,366
Market cap$136.5B
Dividend yield3.80%
Data as of 11:43am ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)-61.67%
Earnings growth (this year)+3.74%
Earnings growth (next 5 years)+6.00%
Revenue growth (last year)-6.20%
P/E ratio12.9
Price/Sales3.80
Price/Book--

Competitors

 Today’s
change
Today’s
% change
AGNAllergan-1.17-0.43%
NVSNovartis+0.12+0.17%
SNYSanofi+0.16+0.42%
BMYBristol-Myers Squibb-0.28-0.47%
Data as of 11:43am ET, 02/12/2016

Financials

Next reporting dateApril 26, 2016
EPS forecast (this quarter)$0.82
Annual revenue (last year)$39.5B
Annual profit (last year)$4.4B
Net profit margin11.25%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman, President &
Chief Executive Officer
Kenneth C. Frazier
Chief Financial Officer &
Executive Vice President
Robert M. Davis
Corporate headquarters
Kenilworth, New Jersey

Forecasts

Partner Offers